Correction: J Ovarian Res 15, 56 (2022)
In the original publication of this article [1], there were mistakes in the article.
1) The word "MS:" in the title refers to manuscript, which should be deleted in the formal document. The authors opted to correct the title to “Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer”.
2) Fig. 3 was wrongly uploaded during the process of article production, which should be replaced by the new figure below.
The original article has been corrected.
Reference
Yin S, Yang L, Zheng Y, et al. MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer. J Ovarian Res. 2022;15:56. https://doi.org/10.1186/s13048-022-00990-6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yin, S., Yang, L., Zheng, Y. et al. Correction: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer. J Ovarian Res 15, 82 (2022). https://doi.org/10.1186/s13048-022-01017-w
Published:
DOI: https://doi.org/10.1186/s13048-022-01017-w